Delivery Order SPE2DR25D6039-SPE2DR26FJ79D
- Not listed
- The Defense Logistics Agency awarded a $11,418.86 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,435.28 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-competitive delivery order, issued on December 12, 2025, represents a firm fixed-price purchase with an ultimate completion date of December 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $14,484.65 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed-price, competitive award with no set-aside designation, with an ultimate completion date of November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,467.96 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. The contract is a firm fixed price delivery order with no set-aside designation, issued on December 4, 2025, with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.70 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram unit. The contract, which was competitively awarded with no set-aside designation, carries a completion date of December 15, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,097.80 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam 10GM, a pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of December 15, 2025, and was awarded on December 12, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $1,402.80 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram unit, with an ultimate completion date of August 22, 2025. This firm fixed-price contract, awarded on August 21, 2025, represents a competitively awarded, non-set-aside order for pharmaceutical supply. The place of performance is listed as the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam (10 grams) with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on September 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,321.59 for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 18, 2025, with completion targeted for December 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under a larger contract vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D6039Indefinite Delivery Contract
- SPE2DR25D6039-SPE2DR26FJ79DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,361.11 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-competitive, firm fixed-price delivery order was issued on December 24, 2025, with an ultimate completion date of December 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents a routine fulfillment under that framework, with the product intended to support Defense Health Agency operations and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 12/23/25 |